30 April 2012 Appendix 4C - Quarterly Cashflow report
16 April 2012 Shareholder Update: April 2012
26 March 2012 Starpharma commences phase 3 trial of VivaGel
22 March 2012 Starpharma commences pivotal phase 3 VivaGel trials for bacterial vaginosis treatment
9 March 2012 International licensing expert Peter Turvey joins Starpharma Board
6 March 2012 Starpharma presenting at Citi investment conference in London
26 February 2012 The Sunday Age / Sydney Morning Herald : Patient route to healthy profits
20 February 2012 Starpharma Interim Report and Half-year Financial Results
14 February 2012 Herald Sun: In the Black
10 February 2012 Bioshares Report: Starpharma Takes Aim at Docetaxel
8 February 2012 Australian Financial Review: Biotechs making a steady recovery
1 February 2012 Starpharma’s dendrimers improve efficacy of docetaxel in animals